Semaglutide is approved as Wegovy (chronic weight management) and Ozempic (type 2 diabetes), both from Novo Nordisk
Conclusion & Outlook The Chinese Retatrutide manufacturing landscape in 2026 offers a diverse range of options for procurement professionals
This led to conviction that GLP-1RAs play a role in the protection against atherosclerosis, mediated by reduction in inflammatory pathways
"I feel this year it's going to click, and I feel really excited to see their reaction," Casselman says
As retatrutide's clinical programme continues to expand, the full safety profile will become clearer through larger and longer-duration studies
For what is anticipated to be a limited set of customers whose clinical needs cannot be met using the increasingly varied set of commercially available FDA-approved GLP-1s, Hims & Hers plans to offer access to compounded GLP-1s if a provider determines that a compounded product is clinically necessary